PE Ratio: 40.78

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/E ratio high or low?

The P/E ratio of 40.78 is 24% below its 3-year average of 53.73, near the low end of its 3-year range (27.64–2255.25).

As of 2026-10-06T15:03:21.716Z. 1.39% above its 12-month average of 40.22.

PE Ratio (40.78) = Close Price ($325.42) / Diluted TTM EPS ($7.98)

KRYS PE Ratio Metrics

P/E vs. its own history

At 40.8, P/E is near its 3-year median — higher than 37% of readings in its 3-year history.

P/E Comparison

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for Krystal Biotech, Inc. (KRYS)?

The P/E ratio for KRYS stock is 40.78.

Is Krystal Biotech, Inc.'s P/E ratio high or low?

The P/E ratio of 40.78 is 24% below its 3-year average of 53.73, near the low end of its 3-year range (27.64–2255.25).

What is the TTM average P/E ratio for Krystal Biotech, Inc. (KRYS)?

The TTM average P/E ratio for KRYS stock is 40.22.

Showing the most recent 260 of 654 data points. The chart above shows the full history.

Related Metrics